❤️

Heart Failure Treatment Overview

Sep 27, 2024

Treatment of Heart Failure

Overview

  • Heart failure treatment involves understanding diagnostics and classifying the severity using the New York Heart Association (NYHA) classification system.
  • Primarily a clinical diagnosis based on symptoms with supporting tests like chest x-ray, BNP levels, echocardiogram, and cardiac catheterization.

Diagnostics Overview

  • Chest X-ray: Can show cardiomegaly, pulmonary edema, and pleural effusions.
  • BNP (Brain Natriuretic Peptide): Elevated levels suggest stress on heart muscles; used to assess treatment effectiveness.
  • Echocardiogram: Gold standard; identifies systolic vs. diastolic heart failure and other heart pathologies.
  • Cardiac Catheterization: Determines underlying causes like ischemic heart disease.

NYHA Classification System

  • Class 1: Symptoms only with extreme exertion
  • Class 2: Symptoms with moderate exertion
  • Class 3: Symptoms with mild exertion
  • Class 4: Symptoms at rest (most severe)

General Treatment Principles

  • Treat underlying diseases: diabetes, hypertension, hyperlipidemia, myocardial infarction, obstructive sleep apnea.
  • Lifestyle changes: restrict sodium (< 2g/day) and water (< 2L/day) intake.

Pharmacological Treatment

Renin-Angiotensin-Aldosterone System (RAAS)

  • ACE Inhibitors (Class 1): Captopril, Enalopril, Lisinopril, Benzapril.
    • Inhibit ACE enzyme, reduce afterload, preload, and stress on heart.
    • Caution: dry cough and angioedema.
  • Angiotensin II Receptor Blockers (ARBs) (Class 1): Losartan, Valsartan, Candesartan.
    • Block angiotensin II actions, similar effects as ACE inhibitors.
  • Aldosterone Antagonists (Class 3): Spironolactone, Eplerenone.
    • Used for class 3 heart failure, post-MI remodeling, potassium sparing.
  • Entresto (Sacubitril/Valsartan) (Class 3): Combines neprilysin inhibitor with ARB to enhance BNP effects and reduce angiotensin II.

Sympathetic Nervous System

  • Beta Blockers (Class 1): Metoprolol, Carvedilol.
    • Reduce heart rate, contractility, and renin release. Contraindicated in decompensated heart failure.
  • Digoxin (Class 4): Increases contractility, used when other treatments fail.
  • Dobutamine: Used in decompensated heart failure to increase cardiac output.

Diuretics

  • Loop Diuretics (Class 2): Furosemide (Lasix).
    • Used to treat fluid overload, pulmonary edema.
  • Thiazide Diuretics (Class 2): Hydrochlorothiazide, Metolazone.
    • Often combined with loop diuretics for enhanced effect.

Vasodilators

  • Hydralazine (Class 3): Used when ACE inhibitors/ARBs are not tolerated; safe in pregnancy.
  • Isosorbide Dinitrate (Class 3): Used for venous dilation, reduces preload.

Decompensated Heart Failure Management

  • Use mnemonic LMNOP:
    • L: Lasix (diuretics)
    • M: Morphine for pain management
    • N: Nitrates (e.g., Hydralazine)
    • O: Oxygen supplementation
    • P: Positioning to alleviate fluid overload in lungs

Conclusion

  • Treatment involves a combination of medications, lifestyle changes, and addressing underlying conditions.
  • Sequential medication use based on patient’s heart failure class and response to treatment.

Resources

  • Facebook and Instagram links available in video description for further engagement.